- Healthgen Biotech's tenth anniversary celebration In 18th Dec 2016, the innovative high-tech enterprise- Wuhan Healthgen Biotechnology Corp.(Healthgen Biotech, Securities Code: 833101) which is focusing on developing, manufacturing and marketing a serious of recombinant proteins and small peptide products in the rice g... Posted by Site editor|2016-12-24 LearnMore
- Recombinant human serum albumin OsrHSA successfully obtained the DMF from U.S. FDA OsrHSA(excipient grade), plant-derived recombinant human serum albumin independently developed by Wuhan Healthgen Biotechnology Corp.(hereinafter referred to as Healthgen Biotech), has officially passed the US Food and Drug Administration (FDA) certification and successfully obta... Posted by Site editor|2015-12-16 LearnMore
- PLOS ONE: Immunotoxicity Assessment of Rice-Derived Recombinant Human Serum Albumin Using Human Peripheral Blood Mononuclear Cells A research team led by Prof. Daichang Yang, from College of Life Sciences, Wuhan University, and Wuhan Healthgen Biotechnology Co., Ltd. started the research and development of using plant-derived therapeutic proteins to replace the plasma-derived ones since 2006, has achieved a ... Posted by Site editor|2014-08-14 LearnMore
- Healthgen Biotech attended the Vaccine World Summit India 2014 Wuhan Healthgen Biotechnology Corp.(Healthgen Biotech) attended the Vaccine World Summit India 2014 at Hyderabad International Convention Centre, India in 4-6 March. Our booth was located in Hall 2. The Vaccine World Summit is the most sought ... Posted by Site editor|2014-03-12 LearnMore
Copyright ® Wuhan Healthgen Biotechnology Corp. All rights reserved. Terms and Conditions of Use
鄂ICP备12013293号-3
